South Africa Gives Conditional Go-Ahead to GSK-Pfizer JV -Reuters
July 02 2019 - 02:10PM
Dow Jones News
--South Africa's Competition Commission gave conditional
approval to a proposed joint venture between pharmaceutical
companies GlaxoSmithKline PLC (GSK) and Pfizer Inc. (PFE), Reuters
reported Tuesday.
--The Commission suggested the JV continue to use South African
manufacturer and packager Spechparm Holdings for three years, in an
effort to alleviate the impact of the deal on local companies
working for Pfizer, the report said.
Full story:
https://www.reuters.com/article/us-pfizer-gsk-jointventure/gsk-pfizer-joint-venture-gets-conditional-approval-from-south-africas-competition-regulator-idUSKCN1TX1MR
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
July 02, 2019 13:55 ET (17:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024